Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I would buy Dr Reddys Laboratories. Surprisingly no matter what the Nifty does, Dr Reddys could go higher. It is a positional trade, it is a day trade. It is something to put on buy list whenever one can and that includes today. The same cannot be said for Cipla but Sun Pharmaceutical Industries is qualifying after a very sharp decline in the same category. Dr Reddys is the best of the pharmaceutical stocks."
At 10:15 hrs Dr Reddys Laboratories was quoting at Rs 2,560, up Rs 28.05, or 1.11 percent. It has touched a 52-week high of Rs 2,560.
The share touched its 52-week high Rs 2,554 and 52-week low Rs 1,720.50 on 26 December, 2013 and 01 March, 2013, respectively. Currently, it is trading 0.23 percent below its 52-week high and 48.79 percent above its 52-week low. Market capitalisation stands at Rs 43,545.53 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
